C12N 2795/10334
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2795/10334 (Use of virus or viral component as vaccine) appears on 6 US grants and 9 published applications in this corpus.
Search patents in C12N- Granted patents
- 6
- Published applications
- 9
- Assignees
- 7
- Inventors
- 16
- Latest grant
- 9 Apr 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 1 |
| 2021 | 1 | 2 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 1 | 1 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Pharmaceutical compositions comprising bacterial delivery vehicles and uses thereof9 Apr 2024US 11,952,594 B2Eligo Bioscience
- Bacteriophage-based vaccines and engineered bacteriophage28 Nov 2023US 11,826,421 B2Athanor Biosciences, Inc.
- Pharmaceutical compositions comprising bacterial delivery vehicles and uses thereof21 Sep 2021US 11,124,776 B2Eligo Bioscience
- Fusion protein comprising bacteriophage λ GpD fused to a GP2 antigen derived from HER-2/neu11 Aug 2020US 10,736,955 B2Theraphage Inc.
- Compositions containing amino acids, phosphate and manganese and their uses12 Sep 2017US 9,758,760 B2The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
- Bacteriophage lambda-vaccine system13 Mar 2025US 2025/0082745 A1The U.S.A., as represented by the Secretary, Department of Health and Human Services
- Bacterial delivery vehicle, process of production and uses thereof27 Jun 2024US 2024/0209326 A1
- Bacterial delivery vehicle, process of production and uses thereof9 Dec 2021US 2021/0380953 A1Eligo Bioscience
- Bacteriophage-Based Vaccines and Engineered Bacteriophage23 Sep 2021US 2021/0290760 A1Athanor Biosciences, Inc.
- Peptide displaying bacteriophage nanoparticles and related compositions and methods30 Jan 2020US 2020/0030433 A1Theraphage Inc.
Most cited
By later US patents
- Compositions containing amino acids, phosphate and manganese and their uses2US 9,234,168 B2The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. · 2016
- Pharmaceutical compositions comprising bacterial delivery vehicles and uses thereof1US 11,124,776 B2Eligo Bioscience · 2021
- Compositions containing amino acids, phosphate and manganese and their uses1US 9,758,760 B2The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. · 2017